A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
(Q53239126)
scientific article published in January 2000
scientific article published in January 2000
Language:
Current Data About
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
other details
| aliases |
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease |
| description | scientific article published in January 2000 |
External Links
| (P356) |
10.1159/000008243
|
| (P698) |
11096224
|